|
|
||||||||||||||
|
|
|||||||||||||||
|
British Journal of Ophthalmology 2005;89:1157-1160; doi:10.1136/bjo.2004.062414 Copyright © 2005 by the BMJ Publishing Group Ltd.
Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trialW G Hodge, K F Damji, W Rock, R Buhrmann, A M Bovell, Y Pan
Department of Ophthalmology, The University of Ottawa Eye Institute, 501 Smyth Road, Ottawa, Ontario, K1H 8L6 Canada
Correspondence to: Background/aims: The efficacy and safety of selective laser trabeculoplasty (SLT) has been found to be equivalent to argon laser trabeculoplasty (ALT). Since SLT produces significantly less disturbance to the trabecular meshwork and is theoretically more repeatable than ALT, it has potential to replace ALT as the standard procedure to treat medically uncontrolled open angle glaucoma. This studys objective is to determine factors that predict successful SLT at 1 year post-treatment.
Methods: As part of a randomised clinical trial comparing the efficacy and safety of SLT to ALT, data on 72 SLT patients were collected, and successful SLT defined as having an SLT induced intraocular pressure (IOP) reduction of
Results: 43 out of the 72 patients who had completed their 1 year follow up visit had an IOP reduction of Conclusion: SLT success was significantly predicted by baseline IOP but not by age, sex, other glaucoma risk factors, type of open angle glaucoma, or by degree of trabecular meshwork pigmentation.
Abbreviations: ALT, argon laser trabeculoplasty; BCVA, best corrected visual acuity; IOP, intraocular pressure; PI, peripheral laser iridotomy; SLT, selective laser trabeculoplasty; TM, trabecular meshwork Keywords: selective laser trabeculoplasty; intraocular pressure; predictors; glaucoma risk factors This article has been cited by other articles:
|
||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |